Borealis is deeply rooted in the Dartmouth College community and uniquely committed to partnering with Dartmouth researchers, students and alumni around the world in building businesses to commercialize their innovations.

Portfolio Companies

logo-adimablogo-avedrologo-avitidelogo-compasslogo-flurrylogo-foodbuzzlogo-glycofilogo-m2s2

Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer Ingelheim (BI). Under the terms of the agreement, Adimab will use [...]

Adimab Provides Year-End Update on 2017 Partnership Activities

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies. In addition, Adimab announced the [...]

Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house

Eli Lilly likes what it sees in Adimab's antibody R&D platform, opting to roll it out at sites in San Diego and New York to help its antibody discovery and optimization activities. The big pharma [...]

Avitide, Inc., Raises Series E Financing from Sands Capital Ventures

Avitide, Inc., the industry leader in the discovery, and manufacture of exclusive biopharmaceutical affinity purification solutions, today announced the closing of a Series E financing. Sands Capital Ventures, LLC led the financing round with participation [...]

Jesse Devitte

Contact Us

We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.

icon-phone 603.643.1500

icon-mail investors@borealisventures.com